Another study that investigated the quantity of Treg in the peripheral blood of colorectal cancer patients showed that the amount of Treg cells in less advanced stages (I+II) was lower than in more advanced stages (III+IV) [21], but those authors investigated CD4+CD25+ cells, making their data difficult to compare with the data from our study. This evidence concerns the gene CD4 and colorectal cancer.